TY - JOUR

T1 - HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1

T2 - Introduction and at the non-hospital settings in the community

AU - Ben Avraham, Binyamin

AU - Crespo-Leiro, Marisa Generosa

AU - Filippatos, Gerasimos

AU - Gotsman, Israel

AU - Seferovic, Petar

AU - Hasin, Tal

AU - Potena, Luciano

AU - Milicic, Davor

AU - Coats, Andrew J. S.

AU - Rosano, Giuseppe

AU - Ruschitzka, Frank

AU - Metra, Marco

AU - Anker, Stefan

AU - Altenberger, Johann

AU - Adamopoulos, Stamatis

AU - Barac, Yaron D.

AU - Chioncel, Ovidiu

AU - De Jonge, Nicolaas

AU - Elliston, Jeremy

AU - Frigeiro, Maria

AU - Goncalvesova, Eva

AU - Grupper, Avishay

AU - Hamdan, Righab

AU - Hammer, Yoav

AU - Hill, Loreena

AU - Itzhaki Ben Zadok, Osnat

AU - Abuhazira, Miriam

AU - Lavee, Jacob

AU - Mullens, Wilfried

AU - Nalbantgil, Sanemn

AU - Piepoli, Massimo F

AU - Ponikowski, Piotr

AU - Ristic, Arsen

AU - Ruhparwar, Arjang

AU - Shaul, Aviv

AU - Tops, Laurens F.

AU - Tsui, Steven

AU - Winnik, Stephan

AU - Jaarsma, Tiny

AU - Gustafsson, Finn

AU - Ben Gal, Tuvia

N1 - Publisher Copyright: © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

PY - 2021

Y1 - 2021

N2 - The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.

AB - The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.

U2 - 10.1002/ehf2.13588

DO - 10.1002/ehf2.13588

M3 - Journal article

C2 - 34519177

AN - SCOPUS:85114895413

VL - 8

SP - 4394

EP - 4408

JO - E S C Heart Failure

JF - E S C Heart Failure

SN - 2055-5822

IS - 6

ER -